ইউরোপীয় ইউনিয়ন -
আইসল্যান্ডীয় -
EMA (European Medicines Agency)
zonisamide mylan
mylan pharmaceuticals limited - zonisamíðs - flogaveiki - antiepileptics, - sér í meðferð hluta flog, með eða án efri almenn ákvörðun er tekin, í fullorðnir með nýlega greind flogaveiki;venjulega meðferð í meðferð hluta flog, með eða án efri almenn ákvörðun er tekin, í fullorðnir, unglingar, og börn sem eru 6 ára og eldri.
ইউরোপীয় ইউনিয়ন -
আইসল্যান্ডীয় -
EMA (European Medicines Agency)
zejula
glaxosmithkline (ireland) limited - niraparib (tosilate monohydrate) - fallopian tube neoplasms; peritoneal neoplasms; ovarian neoplasms - Æxlishemjandi lyf - zejula is indicated: , as monotherapy for the maintenance treatment of adult patients with advanced epithelial (figo stages iii and iv) high-grade ovarian, fallopian tube or primary peritoneal cancer who are in response (complete or partial) following completion of first-line platinum-based chemotherapy. , as monotherapy for the maintenance treatment of adult patients with platinum sensitive relapsed high grade serous epithelial ovarian, fallopian tube, or primary peritoneal cancer who are in response (complete or partial) to platinum based chemotherapy.
আইসলণ্ড -
আইসল্যান্ডীয় -
LYFJASTOFNUN (Icelandic Medicines Agency)
sertralin bluefish filmuhúðuð tafla 50 mg
bluefish pharmaceuticals ab - sertralinum hýdróklóríð - filmuhúðuð tafla - 50 mg
আইসলণ্ড -
আইসল্যান্ডীয় -
LYFJASTOFNUN (Icelandic Medicines Agency)
sertralin bluefish filmuhúðuð tafla 100 mg
bluefish pharmaceuticals ab - sertralinum hýdróklóríð - filmuhúðuð tafla - 100 mg
আইসলণ্ড -
আইসল্যান্ডীয় -
LYFJASTOFNUN (Icelandic Medicines Agency)
salmex innöndunarduft, afmældir skammtar 50 míkróg/500 míkróg/skammt
glenmark pharmaceuticals nordic ab* - salmeterolum xínafóat; fluticasonum própíónat - innöndunarduft, afmældir skammtar - 50 míkróg/500 míkróg/skammt
আইসলণ্ড -
আইসল্যান্ডীয় -
LYFJASTOFNUN (Icelandic Medicines Agency)
salmex innöndunarduft, afmældir skammtar 50 míkróg/100 míkróg/skammt
glenmark pharmaceuticals nordic ab* - salmeterolum xínafóat; fluticasonum própíónat - innöndunarduft, afmældir skammtar - 50 míkróg/100 míkróg/skammt
আইসলণ্ড -
আইসল্যান্ডীয় -
LYFJASTOFNUN (Icelandic Medicines Agency)
mirtazapin bluefish munndreifitafla 15 mg
bluefish pharmaceuticals ab - mirtazapinum inn - munndreifitafla - 15 mg
আইসলণ্ড -
আইসল্যান্ডীয় -
LYFJASTOFNUN (Icelandic Medicines Agency)
mirtazapin bluefish munndreifitafla 30 mg
bluefish pharmaceuticals ab - mirtazapinum inn - munndreifitafla - 30 mg
আইসলণ্ড -
আইসল্যান্ডীয় -
LYFJASTOFNUN (Icelandic Medicines Agency)
salmex innöndunarduft, afmældir skammtar 50 míkróg/250 míkróg/skammt
glenmark pharmaceuticals nordic ab* - salmeterolum xínafóat; fluticasonum própíónat - innöndunarduft, afmældir skammtar - 50 míkróg/250 míkróg/skammt
আইসলণ্ড -
আইসল্যান্ডীয় -
LYFJASTOFNUN (Icelandic Medicines Agency)
xeomin stungulyfsstofn, lausn 100 ein.
merz pharmaceuticals gmbh - botulinum toxin type a - stungulyfsstofn, lausn - 100 ein.